Billiontoone, Inc. balance sheet
At the end of fiscal 2025, Billiontoone, Inc. had total assets of $633m, total liabilities of $153m and shareholders' equity of $480m. It held $496m in cash against $57.2m of debt: net cash of $439m.
Balance sheet
| Fiscal year | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|
| Cash and equivalents | 97 | 191 | 496 | 549 |
| Receivables | — | 25 | 42 | 75 |
| Inventory | — | 9 | 18 | 21 |
| Total current assets | — | 228 | 561 | 651 |
| Total assets | — | 302 | 633 | 730 |
| Accounts payable | — | 4 | 7 | 12 |
| Deferred revenue (current) | — | 3 | 2 | 2 |
| Total current liabilities | — | 28 | 48 | 56 |
| Short-term debt | — | 0 | 0 | — |
| Long-term debt | — | 51 | 57 | 91 |
| Total debt | 0 | 51 | 57 | 91 |
| Total liabilities | — | 134 | 153 | 193 |
| Shareholders' equity | −219 | −252 | 480 | 537 |
| Non-controlling interests and other (assets − liabilities − equity) | — | 419 | — | — |
| Net debt (negative = net cash) | −97 | −140 | −439 | −458 |
| Shares outstanding | — | 22m | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | — | 25 | — | — | 35 | 42 | 61 | 75 |
| Inventory | — | 9 | — | — | 17 | 18 | 19 | 21 |
| Total current assets | — | 228 | — | — | 252 | 561 | 624 | 651 |
| Total assets | — | 302 | — | — | 328 | 633 | 701 | 730 |
| Accounts payable | — | 4 | — | — | 8 | 7 | 9 | 12 |
| Deferred revenue (current) | — | 3 | — | — | 3 | 2 | 3 | 2 |
| Total current liabilities | — | 28 | — | — | 41 | 48 | 57 | 56 |
| Short-term debt | — | 0 | — | — | — | 0 | — | — |
| Long-term debt | — | 51 | — | — | 55 | 57 | 90 | 91 |
| Total debt | — | 51 | — | — | 55 | 57 | 90 | 91 |
| Total liabilities | — | 134 | — | — | 148 | 153 | 195 | 193 |
| Shareholders' equity | −243 | −252 | −253 | −250 | −240 | 480 | 506 | 537 |
| Non-controlling interests and other (assets − liabilities − equity) | — | 419 | — | — | 419 | — | — | — |
| Shares outstanding | — | 11m | — | — | 11m | — | — | — |
Compare with peers
- Twist Bioscience Corp balance sheet
- Castle Biosciences Inc balance sheet
- Fulgent Genetics, Inc. balance sheet
- Veracyte, Inc. balance sheet
- Schrodinger, Inc. balance sheet
Head to head: BLLN vs TWSTBLLN vs CSTLBLLN vs FLGT
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies